Characterization of the Epstein-Barr Virus BZLF1 Protein Transactivation Domain

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1992 Feb 1

PMID 1309920

Citations 46

Authors

E K Flemington

A M Borras

J P Lytle

S H Speck

Affiliations

Soon will be listed here.

Abstract

Initiation of the Epstein-Barr virus (EBV) lytic cycle is dependent on expression of the viral transactivator Zta, which is encoded by the BZLF1 gene. Described here is an initial mapping of the regions of Zta involved in activating transcription. The data indicate that the amino-terminal 153 amino acids of Zta are important for activity, and in particular the region from residues 28 to 78 appears to be critical for Zta function. However, other features of Zta may be important for activity since a Gal4-Zta chimeric protein, generated by fusing the amino-terminal 167 residues of Zta to the DNA binding domain of the yeast transactivator Gal4, transactivated a minimal promoter containing one upstream Gal4 binding site but was unable to exhibit synergistic transactivation when assayed with a reporter containing five upstream Gal4 binding sites.

Citing Articles

Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription.

Ali A, Ohashi M, Casco A, Djavadian R, Eichelberg M, Kenney S PLoS Pathog. 2022; 18(9):e1010886.

PMID: 36174106 PMC: 9553042. DOI: 10.1371/journal.ppat.1010886.

Epstein-Barr virus: Biology and clinical disease.

Damania B, Kenney S, Raab-Traub N Cell. 2022; 185(20):3652-3670.

PMID: 36113467 PMC: 9529843. DOI: 10.1016/j.cell.2022.08.026.

Epstein-Barr Virus Enhances Cancer-Specific Aberrant Splicing of TSG101 Pre-mRNA.

Chua H, Kameyama T, Mayeda A, Yeh T Int J Mol Sci. 2022; 23(5).

PMID: 35269659 PMC: 8910672. DOI: 10.3390/ijms23052516.

Interaction of phospholipid scramblase 1 with the Epstein-Barr virus protein BZLF1 represses BZLF1-mediated lytic gene transcription.

Kusano S, Ikeda M J Biol Chem. 2019; 294(41):15104-15116.

PMID: 31434743 PMC: 6791327. DOI: 10.1074/jbc.RA119.008193.

T cell epitope clustering in the highly immunogenic BZLF1 antigen of Epstein-Barr virus.

Rist M, Neller M, Burrows J, Burrows S J Virol. 2014; 89(1):703-12.

PMID: 25355876 PMC: 4301143. DOI: 10.1128/JVI.02642-14.

References

Lieberman P, Berk A . In vitro transcriptional activation, dimerization, and DNA-binding specificity of the Epstein-Barr virus Zta protein. J Virol. 1990; 64(6):2560-8. PMC: 249432. DOI: 10.1128/JVI.64.6.2560-2568.1990. View

Packham G, Economou A, Rooney C, Rowe D, Farrell P . Structure and function of the Epstein-Barr virus BZLF1 protein. J Virol. 1990; 64(5):2110-6. PMC: 249368. DOI: 10.1128/JVI.64.5.2110-2116.1990. View

Lin Y, Carey M, Ptashne M, Green M . How different eukaryotic transcriptional activators can cooperate promiscuously. Nature. 1990; 345(6273):359-61. DOI: 10.1038/345359a0. View

Mermod N, ONeill E, Kelly T, Tjian R . The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain. Cell. 1989; 58(4):741-53. DOI: 10.1016/0092-8674(89)90108-6. View

Gruffat H, Moreno N, Sergeant A . The Epstein-Barr virus (EBV) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z. J Virol. 1990; 64(6):2810-8. PMC: 249462. DOI: 10.1128/JVI.64.6.2810-2818.1990. View

Flemington E, Speck S . Epstein-Barr virus BZLF1 trans activator induces the promoter of a cellular cognate gene, c-fos. J Virol. 1990; 64(9):4549-52. PMC: 247926. DOI: 10.1128/JVI.64.9.4549-4552.1990. View

Flemington E, Speck S . Evidence for coiled-coil dimer formation by an Epstein-Barr virus transactivator that lacks a heptad repeat of leucine residues. Proc Natl Acad Sci U S A. 1990; 87(23):9459-63. PMC: 55185. DOI: 10.1073/pnas.87.23.9459. View

Takada K, Ono Y . Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J Virol. 1989; 63(1):445-9. PMC: 247705. DOI: 10.1128/JVI.63.1.445-449.1989. View

Farrell P, Rowe D, Rooney C, Kouzarides T . Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos. EMBO J. 1989; 8(1):127-32. PMC: 400780. DOI: 10.1002/j.1460-2075.1989.tb03356.x. View

10.

Woisetschlaeger M, Strominger J, Speck S . Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes. Proc Natl Acad Sci U S A. 1989; 86(17):6498-502. PMC: 297871. DOI: 10.1073/pnas.86.17.6498. View

11.

Countryman J, Jenson H, Seibl R, Wolf H, Miller G . Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency. J Virol. 1987; 61(12):3672-9. PMC: 255978. DOI: 10.1128/JVI.61.12.3672-3679.1987. View

12.

Countryman J, Miller G . Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci U S A. 1985; 82(12):4085-9. PMC: 397939. DOI: 10.1073/pnas.82.12.4085. View

13.

Biggin M, Bodescot M, Perricaudet M, Farrell P . Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells. J Virol. 1987; 61(10):3120-32. PMC: 255889. DOI: 10.1128/JVI.61.10.3120-3132.1987. View

14.

Sadowski I, Ma J, Triezenberg S, Ptashne M . GAL4-VP16 is an unusually potent transcriptional activator. Nature. 1988; 335(6190):563-4. DOI: 10.1038/335563a0. View

15.

Hope I, Struhl K . GCN4 protein, synthesized in vitro, binds HIS3 regulatory sequences: implications for general control of amino acid biosynthetic genes in yeast. Cell. 1985; 43(1):177-88. DOI: 10.1016/0092-8674(85)90022-4. View

16.

Krieg P, Melton D . Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs. Nucleic Acids Res. 1984; 12(18):7057-70. PMC: 320142. DOI: 10.1093/nar/12.18.7057. View

17.

Bauer G, Hofler P, zur Hausen H . Epstein-Barr virus induction by a serum factor. I. Induction and cooperation with additional inducers. Virology. 1982; 121(1):184-94. DOI: 10.1016/0042-6822(82)90128-3. View

18.

Miller G, RABSON M, Heston L . Epstein-Barr virus with heterogeneous DNA disrupts latency. J Virol. 1984; 50(1):174-82. PMC: 255597. DOI: 10.1128/JVI.50.1.174-182.1984. View

19.

Gorman C, Moffat L, Howard B . Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982; 2(9):1044-51. PMC: 369897. DOI: 10.1128/mcb.2.9.1044-1051.1982. View

20.

Kallin B, Luka J, Klein G . Immunochemical characterization of Epstein-Barr virus-associated early and late antigens in n-butyrate-treated P3HR-1 cells. J Virol. 1979; 32(3):710-6. PMC: 525917. DOI: 10.1128/JVI.32.3.710-716.1979. View